Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-18

FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for Diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals. The product is a calcium channel blocker us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride extended release (Diltiazem hydrochloride)

Snippet

SUPPL AP for DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE (DILTIAZEM HYDROCHLORIDE)